CLINICAL_TRIALS
trial_result
· 2012-03-21
Clinical Trial Update: Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial update comparing safety and efficacy of exenatide once weekly versus liraglutide in adults with type 2 diabetes; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2012-03-21